Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

Key Findings

• ●Classification refinements from consensus group, WHO, and ECNM
• ●New treatment options including allogeneic HSCT and KIT D816V inhibitors

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.